4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-23-007364
Chief Financial Officer sold 1,566 shares at $2.36 ($3,696)
- Chief Financial Officer acquired 3,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Broadfoot Jill Marie Chief Financial Officer | 2023-02-03 | Option exercise | +3,750 | 17,026 | D | ||
| Broadfoot Jill Marie Chief Financial Officer | 2023-02-06 | Sale | −1,566 | $2.36 | $3,696 | 15,460 | D |
| Derivatives | |||||||
| Broadfoot Jill Marie Chief Financial Officer | 2023-02-03 | Option exercise · Restricted Stock Unit | −3,750 | 11,250 | D | ||
| Open-market sales · 1,566 sh · avg $2.36 · $3,696 | |||||||
Loading xslF345X03/doc4.xml…